Business Monitor International


Filter results

Pharmaceutical Industry Reports

Showing 1-20 of 97
Sort By
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

Pub date:12 Nov 2014

BMI View:   Against a backdrop of economic growth, the Algerian government commitment to expand and upgrade medical coverage and healthcare services in Algeria will translate in growing commercial opportunities for pharmaceutical and healthcare industries over ...
$1,295.00
Read More...
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

Pub date:13 Nov 2014

BMI View: The Angolan government ' s initiatives to make healthcare more affordable, coupled with the municipalisation of health services, will lead to greater access to medical services and increase pharmaceutical spending in Angola. A ...
$1,295.00
Read More...
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

Pub date:22 Aug 2014

BMI View:   We expect increasing competitive pressure in the A rgentine pharmaceutical sector as South-South relations continue to develop. This is illustrated by the Argentine government recent authorization for Indian pharmaceutical firms to export finished ...
$1,295.00
Read More...
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

Pub date:05 Nov 2014

BMI View:   The Australian government will continue to use drug price controls as a means to reduce healthcare expenditure. Our view is based on the government's runaway budget deficit and the inevitable increased demand for ...
$1,295.00
Read More...
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

Pub date:12 Sep 2014

BMI View:   The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. While the market will continue to be affected by the drug pricing ...
$1,295.00
Read More...
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Bahrain ' s pharmaceutical market ou tlook over the medium- and long- term remain bullish despite recent price cuts made to a v ariety of medicines across the country ,   contributing to only moderate ...
$1,295.00
Read More...
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

Pub date:12 Sep 2014

BMI View:   We consider Bangladesh 's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound ...
$1,295.00
Read More...
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

Pub date:24 Sep 2014

BMI View: The Belarusian economy is set to suffer a prolonged period of economic instability as a result of a decline in global potash prices and an escalating trade war with Russia. If Russo-Belarusian relations ...
$1,295.00
Read More...
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Multinational firms find Belgium to be an attractive investment destination as a European hub for clinical trials, new drug development and niche research. Even though per capita spending on pharmaceuticals is relatively high, ...
$1,295.00
Read More...
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

Pub date:02 Sep 2014

BMI View:   Our outlook for the pharmaceutical and healthcare markets of Botswana is reasonably positive due to the government's increasing commitment to improve the country's healthcare sector. The country's import reliance for pharmaceuticals, coupled with ...
$1,295.00
Read More...
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

Pub date:04 Sep 2014

BMI View:   Brazil's traditional commitment to healthcare, strong government support for the provision of medical services, promising private healthcare growth and the expanding middle-class mean that there are significant revenue-generating opportunities for drugmakers, medical device ...
$1,295.00
Read More...
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

Pub date:12 Nov 2014

BMI View:  Large order increases from within the hospital sector and robust consumer demand  will  spur pharmaceutical sales growth in 2014 and 2015. However, external slowdown will begin to impact the Bulgarian market from 2015 onwards. Bulgaria's healthcare ...
$1,295.00
Read More...
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

Pub date:26 Sep 2014

BMI View: The current lack of investment in healthcare in Cambodia will continue to deter foreign pharmaceutical firms from entering the country .   Consequently, we highlight that Cambodia will remain one of the least attractive markets ...
$1,295.00
Read More...
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

Pub date:27 Aug 2014

BMI View : Against a backdrop of sustained economic growth, Cameroon's pharmaceuticals and healthcare market will sustain an expansive trajectory over the medium-to-long term. Although from a low per-capita spending level, population growth and rising incomes ...
$1,295.00
Read More...
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

Pub date:02 Sep 2014

BMI View:   Canada   will continue to attract pharmaceutical companies to lau n ch innovative medicines due to the hospitable business environment, improving healthcare coverage and broader drug reimbursement lists.   The regulatory authority also encourages pharmaceutical ...
$1,295.00
Read More...
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

Pub date:11 Sep 2014

BMI View: Costa Rica and Panama will continue to outperfor m other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize . The business-friendly environment, high per-capita medicine spending and strong consumer demand still ...
$1,295.00
Read More...
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

Pub date:08 Oct 2014

BMI View: Improving standards of intellectual property protection will provide incentives for both local and foreign pharmaceutical companies to have long-term strategies in Chile. In addition, Chile's open economy, relatively efficient legal framework, business-friendly environment ...
$1,295.00
Read More...
China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report

Pub date:04 Sep 2014

BMI View:  A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown on illegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential. However, over the long term, the government ...
$1,295.00
Read More...
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

Pub date:27 Aug 2014

BMI View:   President Juan Manuel Santos' re-election in June has given him a strong mandate to continue the process of healthcare reform in Colombia. Although the Santos administration has been successful in limit ing medicine ...
$1,295.00
Read More...
Cote d'Ivoire Pharmaceuticals & Healthcare Report

Cote d'Ivoire Pharmaceuticals & Healthcare Report

Pub date:12 Nov 2014

BMI View:   Côte d'Ivoire's healthcare sector will continue to be underfunded, making it difficult for the country to achieve its healthcare-related millennium development goals. This poses questions regarding the population's access to treatment of ...
$1,295.00
Read More...
Showing 1-20 of 97
Sort By